Compare MLSS & SACH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MLSS | SACH |
|---|---|---|
| Founded | 1989 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.6M | 38.4M |
| IPO Year | 1996 | 2016 |
| Metric | MLSS | SACH |
|---|---|---|
| Price | $0.56 | $0.79 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 2 |
| Target Price | $1.00 | ★ $2.00 |
| AVG Volume (30 Days) | ★ 133.3K | 104.9K |
| Earning Date | 05-14-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 19.23% |
| EPS Growth | N/A | ★ 104.30 |
| EPS | ★ N/A | N/A |
| Revenue | $8,973,982.00 | ★ $57,500,000.00 |
| Revenue This Year | $12.64 | $145.00 |
| Revenue Next Year | $8.99 | $6.80 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 3.99 | N/A |
| 52 Week Low | $0.22 | $0.77 |
| 52 Week High | $0.68 | $1.45 |
| Indicator | MLSS | SACH |
|---|---|---|
| Relative Strength Index (RSI) | 73.26 | 37.95 |
| Support Level | $0.25 | $0.77 |
| Resistance Level | N/A | $0.87 |
| Average True Range (ATR) | 0.04 | 0.03 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 86.19 | 26.30 |
Milestone Scientific Inc develops and commercializes proprietary computer-controlled drug delivery systems designed to enhance the safety, precision, and patient experience associated with subcutaneous injections and fluid aspiration procedures. The company's core technology platform, Dynamic Pressure Sensing (DPS) Technology, controls flow rate and measures pressure at the needle tip in real time. DPS Technology is incorporated into both the company's dental and medical products and supports clinical applications, including local anesthesia delivery, epidural space identification in regional anesthesia procedures, and intra-articular joint injections. It operates in two segments: Dental, which markets and sells its dental products, and Medical, markets and sells its medical products.
Sachem Capital Corp is a real estate investment trust. The company specializes in originating, underwriting, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real property located in Connecticut. Its primary objective is to grow the loan portfolio while protecting and preserving capital in a manner that provides for attractive risk-adjusted returns to shareholders over the long term through dividends. The company earns the majority of its revenue through Interest income from loans.